JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martínez, V.
Right arrow Articles by Taché, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martínez, V.
Right arrow Articles by Taché, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATROPINE

Vol. 293, Issue 3, 1099-1105, June 2000

Intracisternal Injection of Somatostatin Receptor 5-Preferring Agonists Induces a Vagal Cholinergic Stimulation of Gastric Emptying in Rats1

Vicente Martínez2 , Jean Rivier, David Coy and Yvette Taché

CURE: Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Department of Medicine, Digestive Diseases Division and Brain Research Institute, UCLA School of Medicine, Los Angeles, California (V.M., Y.T.); Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, California (J.R.); and Peptide Research Laboratories, Department of Medicine, Tulane University Medical Center, New Orleans, Louisiana (D.C.)

We previously showed that the somatostatin receptor 5 (sst5)-preferring agonist BIM-23052 injected intracisternally (i.c.; 0.8 nmol/rat) stimulated gastric emptying of a non-nutrient meal in conscious rats. In this study, we investigated the neural pathways and specificity of BIM-23052 action. BIM-23052 (0.4, 0.8, and 1.2 nmol/rat i.c.) stimulated gastric transit; values of gastric emptying were 65.5 ± 6.5, 77.4 ± 5.3, and 77.7 ± 1.9%, respectively, compared with 43.2 ±3.2% in i.c. saline group. Intravenous injection of BIM-23052 (0.8 nmol/rat) had no effect. BIM-23052 (0.8 nmol/rat i.c.) action was prevented by subdiaphragmatic vagotomy or atropine. Medullary thyrotropin-releasing hormone (TRH) is known to play a physiological role in the vagal stimulation of gastric motor function. TRH receptor antisense oligodeoxynucleotides injected i.c. with a regimen that prevented TRH (0.3 nmol/rat i.c.)-induced enhanced gastric emptying did not influence BIM-23052 stimulatory action. Somatostatin-28 (0.2-1.2 nmol/rat i.c.), which possesses a higher affinity than somatostatin-14 for sst5, and the cyclic octapeptide des-AA1,2,4,5,12,13[D-Trp8]somatostatin (0.2-1.2 nmol/rat i.c.), an oligo-somatostatin analog that shares similar brain actions as somatostatin-28, induced a dose-related stimulation of gastric emptying. Somatostatin-14 and the preferring peptide agonists for sst1, CH-275; sst2, DC-32-87; sst3, BIM-23056 and L-796,778; and sst4, L-803,087 had no significant effect on gastric emptying when injected i.c. at 0.8 nmol/rat. These results show that BIM-23056 injected i.c. acts in the brain independently from medullary TRH to induce a vagal cholinergic stimulation of gastric emptying through the sst5 receptor subtype.


1 This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-33061 (to Y.T), DK-41301 (Center Grant, Animal Core, to Y.T.), and DK-50124 (to J.R.).

2 Current address: Centro de Estudios Universitarios San Pablo, Veterinary School, Department of Physiology, 46113-Moncada, Valencia, Spain. E-mail: vmartine{at}ceu.upv.es


0022-3565/00/2933-1099$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.